Unlike FISH in which analysis on 20 adjacent breast cancer cells was considered sufficient to establish a HER2-positive status, results from ddPCR without microdissection represent HER2 status across different parts of the tumor. The gene discussed is ERBB2; the disease is breast carcinoma.